Your browser doesn't support javascript.
loading
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
Laurent, Camille; Nicolae, Alina; Laurent, Cécile; Le Bras, Fabien; Haioun, Corinne; Fataccioli, Virginie; Amara, Nadia; Adélaïde, José; Guille, Arnaud; Schiano, Jean-Marc; Tesson, Bruno; Traverse-Glehen, Alexandra; Chenard, Marie-Pierre; Mescam, Lénaïg; Moreau, Anne; Chassagne-Clement, Catherine; Somja, Joan; Escudié, Frédéric; André, Marc; Martin, Nadine; Lacroix, Laetitia; Lemonnier, François; Hamy, Anne-Sophie; Reyal, Fabien; Bannier, Marie; Oberic, Lucie; Prade, Nais; Frénois, François-Xavier; Beldi-Ferchiou, Asma; Delfau-Larue, Marie-Helene; Bouabdallah, Reda; Birnbaum, Daniel; Brousset, Pierre; Xerri, Luc; Gaulard, Philippe.
Afiliação
  • Laurent C; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Toulouse,Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Nicolae A; Centre de Recherche en Cancerologie de Toulouse, INSERM, UMR1037 laboratoire d'excellence Toulouse Cancer (Labex TOUCAN), Paul Sabatier University Toulouse III, Toulouse, France.
  • Laurent C; Pathology and Cytology Department, Centre Hospitalier Universitaire Hautepierre, Strasbourg, France.
  • Le Bras F; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.
  • Haioun C; Institut Carnot CALYM, Lymphoma Academic Research Organisation, Institut Carnot, Pierre-Bénite, France.
  • Fataccioli V; Lymphoid Malignancies Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Henri Mondor-Albert Chenevier, Créteil, France.
  • Amara N; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.
  • Adélaïde J; Lymphoid Malignancies Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Henri Mondor-Albert Chenevier, Créteil, France.
  • Guille A; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.
  • Schiano JM; Department of Pathology, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France.
  • Tesson B; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Toulouse,Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Traverse-Glehen A; Department of Predictive Oncology, Institut Paoli-Calmettes, and.
  • Chenard MP; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR7258, Aix-Marseille University, UM105, Marseille, France.
  • Mescam L; Department of Predictive Oncology, Institut Paoli-Calmettes, and.
  • Moreau A; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR7258, Aix-Marseille University, UM105, Marseille, France.
  • Chassagne-Clement C; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
  • Somja J; Institut Carnot CALYM, Lymphoma Academic Research Organisation, Institut Carnot, Pierre-Bénite, France.
  • Escudié F; Pathology Department, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
  • André M; Pathology and Cytology Department, Centre Hospitalier Universitaire Hautepierre, Strasbourg, France.
  • Martin N; Department of Bio-Pathology Institut Paoli-Calmettes, Marseille, France.
  • Lacroix L; Pathology and Cytology Department, Centre Hospitalier Hôtel Dieu, Nantes, France.
  • Lemonnier F; Department of Bio-Pathology Pathology and Cytology Department, Centre Léon Bérard, Lyon, France.
  • Hamy AS; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Liège, Liège, Belgium.
  • Reyal F; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Toulouse,Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Bannier M; Department of Hematology, Centre Hospitalo-Universitaire UCLouvain Namur, Yvoir, Belgium.
  • Oberic L; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.
  • Prade N; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.
  • Frénois FX; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.
  • Beldi-Ferchiou A; Lymphoid Malignancies Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Henri Mondor-Albert Chenevier, Créteil, France.
  • Delfau-Larue MH; Curie Institute, Residual Tumour and Response to Treatment Laboratory, RT2Lab, INSERM, U 932 Immunity and Cancer, Paris, France.
  • Bouabdallah R; Curie Institute, Residual Tumour and Response to Treatment Laboratory, RT2Lab, INSERM, U 932 Immunity and Cancer, Paris, France.
  • Birnbaum D; Curie Institute, Department of Surgery, Paris Descartes University, Paris, France.
  • Brousset P; Department of Surgery, Institut Paoli-Calmettes, Marseille, France.
  • Xerri L; Hematology Department and.
  • Gaulard P; Laboratory of Hematology, Centre Hospitalo-Universitaire de Toulouse, Institut Universitaire de Cancérologie de Toulouse, Toulouse, France; and.
Blood ; 135(5): 360-370, 2020 01 30.
Article em En | MEDLINE | ID: mdl-31774495

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Linfoma Anaplásico de Células Grandes / Implantes de Mama / Epigênese Genética / Fatores de Transcrição STAT / Janus Quinases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Linfoma Anaplásico de Células Grandes / Implantes de Mama / Epigênese Genética / Fatores de Transcrição STAT / Janus Quinases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França